Background
During HCV active chronic infection, HIV co-infection promotes liver fibrogenesis and accelerates the progression towards cirrhosis. After sustained virological response (SVR), liver stiffness (LS) usually decreases, regardless of HIV co-infection. However, information related to the impact of HIV co-infection on LS dynamics in this subset is scarce.
Methods
Multicenter prospective study conducted in the GEHEP-011 cohort (ID NCT04460157), including patients with chronic HCV infection, with and without HIV co-infection, fulfilling: 1) SVR with direct-acting antivirals based regimens; 2) pre-treatment LS ≥9.5kPa; 3) available measurement of LS at SVR. Pre-treatment (baseline), SVR and then, annual post-treatment LS were assessed by vibration-controlled transient elastography. The primary outcome was the time to LS normalization achievement (≤7.2kPa). To control confounding biases between the two subgroups, a propensity score (PS) for HIV was calculated. Two Fine-Gray regression models for competing risks (death was the competing event) were performed: i) using the PS as a covariate; ii) matching individuals whit and without HIV co-infection by PS. ChatGPT (version GPT-4) was used for assistance with statistical coding.
Results
1,138 patients were included, 678 (60%) people living with HIV (PLWH). Median LS value at baseline (Q1-Q3) was 17.3 kPa (11.8-27.0) in PLWH and 15.4 kPa (11.8-26.4) in persons with mono-infection (p=0.170). The median time between the first to the last measure was 35 (17-69) months. LS dynamics are shown in Fig. 1. LS dynamics differed between patients with and without HIV co-infection (p < 0.001). In total, 456 (40.1%) patients achieved LS normalization (Fig. 2), 192 (42%) individuals with HCV mono-infection and 264 (21%) PLWH (p=0.003). In the multivariate analysis regression adjusted by HIV, PS and diabetes, HIV was associated with a lower probability of achieving normalization [sHR=0.70 (95% CI, 0.56-0.88), p=0.001]. Matching by closer PS was performed. In this subset, the probability of achieving LS normalization was again lower in PLWH [sHR=0.74 (95% CI, 0.60-0.92), p=0.006].
Conclusions
After SVR, the probability of reaching LS normalization is significantly lower and later in PLWH, even after an extensive adjustment for multiple potential confounders. Factors as inflammation and immunosenescence associated with HIV may be relevant in the impairment of fibrosis reversal. This could have implications on the development of long-term clinical events.